Om

Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for serious cardiopulmonary and immune-mediated diseases. Its lead program is seralutinib, an investigational inhaled therapy being studied for pulmonary arterial hypertension and pulmonary hypertension associated with interstitial lung disease. The company also maintains a broader research pipeline that includes additional candidates across immunology, inflammation, and oncology, reflecting a focus on complex diseases with limited treatment options. Gossamer Bio works to advance its programs through clinical development and partnerships, positioning itself as a specialized biotechnology company centered on rare and chronic conditions. Headquartered in San Diego, California, Gossamer Bio serves as a development-stage player in the biopharmaceutical market.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I GOSSAMER BIO MED ENDAVU: Køb Gossamer Bio ($GOSS) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Gossamer Bio, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.